Notice to healthcare providers and public health officials : Updated guidance for the evaluation of severe respiratory illness associated with Middle East Respiratory Syndrome coronavirus (MERS-CoV)

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  August 12, 2013, (12:00 PM ET)
  
  CDCHAN-00352
  
  The Centers for Disease Control and Prevention (CDC) continues to work closely with the World Health Organization (WHO) and other partners to better understand the public health risks posed by Middle East Respiratory Syndrome Coronavirus (MERS-CoV). To date, no cases have been reported in the United States. The purpose of this health update is 1) to provide updated guidance to healthcare providers and state and local health departments regarding who should be tested for M ERS-CoV infection, 2) to make them aware of changes to CDC’s “probable case” definition, and 3) to clarify what specimens should be obtained when testing for MERS-CoV. Please disseminate this information to infectious disease specialists, intensive care physicians, primary care physicians, and infection preventionists, as well as to emergency departments and microbiology laboratories.
  
  
• Subjects:
  Communicable Disease Control Middle East Respiratory Syndrome Coronavirus Respiratory Tract Infections Severe Acute Respiratory Syndrome
• Source:
  HAN ; 352
• Series:
  Health Alert Network
• Document Type:
  HAN Health Update
• Pages in Document:
  2 unnumbered pages
• Issue:
  352
• Collection(s):
  Health Alert Network (HAN)
• Main Document Checksum:
  urn:sha-512:a68fffed08a67d580067a93674d8e3ba7a4214ce24233cd2223689dbf30859f9a2bf6a13b8d50c2373b1f4db343b3dbe10788c32734a5c670b7f3f6d26be62f6
• Download URL:
  https://stacks.cdc.gov/view/cdc/25261/cdc_25261_DS1.pdf
• File Type:
  [PDF - 1.59 MB ]